Discovery of oral simnotrelvir, an approved SARS-CoV-2 3C-like protease inhibitor for the treatment of COVID-19
Jiang, X., Su, H.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
3C-like proteinase nsp5 | 306 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  EC: 3.4.22.69 | ||
UniProt | |||||
Find proteins for P0DTD1 (Severe acute respiratory syndrome coronavirus 2) Explore P0DTD1  Go to UniProtKB:  P0DTD1 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P0DTD1 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
I1Z (Subject of Investigation/LOI) Query on I1Z | B [auth A] | (1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide C26 H44 N6 O4 NJQHWGAQENWSGZ-CSXXOYNESA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 45.564 | α = 90 |
b = 63.918 | β = 90 |
c = 105.364 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
Aimless | data scaling |
PHASER | phasing |
XDS | data reduction |
Funding Organization | Location | Grant Number |
---|---|---|
Not funded | -- |